The birth of ChatGPT, a cutting-edge language model chatbot developed by
OpenAI, ushered in a new era in AI, and this paper vividly showcases its
innovative application within the field of drug discovery. Focused specifically
on developing anti-cocaine addiction drugs, the study employs GPT-4 as a
virtual guide, offering strategic and methodological insights to researchers
working on generative models for drug candidates. The primary objective is to
generate optimal drug-like molecules with desired properties. By leveraging the
capabilities of ChatGPT, the study introduces a novel approach to the drug
discovery process. This symbiotic partnership between AI and researchers
transforms how drug development is approached. Chatbots become facilitators,
steering researchers towards innovative methodologies and productive paths for
creating effective drug candidates. This research sheds light on the
collaborative synergy between human expertise and AI assistance, wherein
ChatGPT's cognitive abilities enhance the design and development of potential
pharmaceutical solutions. This paper not only explores the integration of
advanced AI in drug discovery but also reimagines the landscape by advocating
for AI-powered chatbots as trailblazers in revolutionizing therapeutic
innovation